This protocol is judged by an institutional assessment board, an unbiased team that assessments any scientific trials involving individuals. If a study entails a Plan I drug, once the board approves the protocol as moral, the researchers have to submit an application for an investigational new drug (IND) variety within the FDA.Dihydrocodeine is rea